SCHEMBL26961985

SCHEMBL26961985

CC(C)(C)C(=O)NNC(=O)c1ccc2c(c1)NC(=O)[C@@H](NC(=O)O)CS2

nearest known ligand 0.42

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ HDAC1 Q13547 2/20 0.42
▸ HDAC8 Q9BY41 2/20 0.42
▸ HDAC6 Q9UBN7 2/20 0.42
▸ RAB9A P51151 5/20 0.40
▸ KDM4E B2RXH2 4/20 0.40
▸ HPGD P15428 2/20 0.40
▸ LMNA P02545 3/20 0.40
▸ HTT P42858 2/20 0.40
▸ NPSR1 Q6W5P4 1/20 0.40
▸ SMN1; SMN2 Q16637 3/20 0.40
▸ MAPT P10636 1/20 0.40
▸ KMT2A Q03164 1/20 0.39
▸ POLB P06746 2/20 0.39
▸ NPC1 O15118 4/20 0.38
▸ ALDH1A1 P00352 1/20 0.38
▸ ATM Q13315 1/20 0.37
▸ PYGL P06737 1/20 0.36
▸ PYGM P11217 1/20 0.36
▸ PABPC1 P11940 1/20 0.35
▸ HSD17B10 Q99714 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL26962726 0.88 HDAC1 (0.39) HDAC1HDAC8HDAC6RAB9AKDM4E
SCHEMBL29796820 0.88 HDAC1 (0.39) HDAC1HDAC8HDAC6RAB9AKDM4E
SCHEMBL31375556 0.86 NAAA (0.40) HDAC1HDAC8HDAC6RAB9AHPGD
SCHEMBL31628244 0.86 NAAA (0.40) HDAC1HDAC8HDAC6RAB9AHPGD
SCHEMBL27125391 0.83 KDM4E (0.33) HDAC1HDAC8HDAC6RAB9AKDM4E
SCHEMBL26962775 0.83 KDM4E (0.33) HDAC1HDAC8HDAC6RAB9AKDM4E
SCHEMBL26962754 0.83 HDAC1 (0.44) HDAC1HDAC8HDAC6RAB9AKDM4E
SCHEMBL29270794 0.82 HDAC1 (0.39) HDAC1HDAC8HDAC6RAB9AHPGD
SCHEMBL31628254 0.80 HDAC1 (0.40) HDAC1HDAC8HDAC6RAB9AHPGD
SCHEMBL30830316 0.79 KMT2A (0.36) HDAC1HDAC8HDAC6RAB9AKDM4E

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-4291558-A1 BICYCLIC TETRAHYDROAZEPINE DERIVATIVES FOR THE TREATMENT OF CANCER F. Hoffmann-La Roche AG (CH) 2023-12-20 — — EP disclosed
Send feedback